These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18894887)

  • 1. Studies on the laxative activity of triphenylmethane derivatives; relationship between structure and activity of phenolphthalein congeners.
    LOEWE S
    J Pharmacol Exp Ther; 1948 Nov; 94(3):288-98. PubMed ID: 18894887
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the laxative activity of triphenylmethane derivatives; physicochemical aspects of the potency difference between yellow phenolphthalein and U.S.P. phenolphthalein.
    LOEWE S; LOEWE IA
    Arch Int Pharmacodyn Ther; 1949 Aug; 80(2-3):236-45. PubMed ID: 18137859
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the laxative activity of triphenylmethane derivatives; physical characteristics of phenolphthalein in relation to yellow phenolphthalein activation.
    LOEWE S; LOEWE IA
    Arch Int Pharmacodyn Ther; 1949 Aug; 80(2-3):246-54. PubMed ID: 18137860
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the laxative activity of triphenylmethane derivative; the relation between water-repellency and activation of phenolphthalein preparations and the concept of floto activation.
    LOEWE S; LOEWE IA
    Arch Int Pharmacodyn Ther; 1950 Feb; 81(2):195-206. PubMed ID: 15410271
    [No Abstract]   [Full Text] [Related]  

  • 5. [THE LAXATIVE ACTION OF SOME TRIPHENYLMETHANE DERIVATIVES].
    HACKENTHAL E; STUTTE HJ; JUNGMANN B
    Arzneimittelforschung; 1963 Aug; 13():657-60. PubMed ID: 14090433
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of three laxatives and a cation exchange resin on fecal sodium and potassium excretion.
    Emmett M; Hootkins RE; Fine KD; Santa Ana CA; Porter JL; Fordtran JS
    Gastroenterology; 1995 Mar; 108(3):752-60. PubMed ID: 7875477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of ovarian cancer in relation to use of phenolphthalein-containing laxatives.
    Cooper GS; Longnecker MP; Sandler DP; Ness RB
    Br J Cancer; 2000 Aug; 83(3):404-6. PubMed ID: 10917559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenolphthalein-containing laxative use in relation to adenomatous colorectal polyps in three studies.
    Longnecker MP; Sandler DP; Haile RW; Sandler RS
    Environ Health Perspect; 1997 Nov; 105(11):1210-2. PubMed ID: 9370521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer risk and use of phenolphthalein-containing laxatives.
    Cooper GS; Longnecker MP; Peters RK
    Pharmacoepidemiol Drug Saf; 2004 Jan; 13(1):35-9. PubMed ID: 14971121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Are anthraquinone laxatives transferred to breast milk?].
    FRIEBEL H; WALKOWIAK L
    Med Klin; 1951 Feb; 46(7):208-9. PubMed ID: 14842489
    [No Abstract]   [Full Text] [Related]  

  • 11. Laxative use not a risk for colorectal cancer: data from the Melbourne Colorectal Cancer Study.
    Kune GA
    Z Gastroenterol; 1993 Feb; 31(2):140-3. PubMed ID: 8465555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laxatives: chemical structure and potency of phthaleins and hydroxyanthraquinones.
    HUBACHER MH; DOERNBERG S; HORNER A
    J Am Pharm Assoc Am Pharm Assoc; 1953 Jan; 42(1):23-30. PubMed ID: 13034620
    [No Abstract]   [Full Text] [Related]  

  • 13. Nitric oxide as a mediator of bisacodyl and phenolphthalein laxative action: induction of nitric oxide synthase.
    Gaginella TS; Mascolo N; Izzo AA; Autore G; Capasso F
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1239-45. PubMed ID: 7523656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo estrogenic and antiestrogenic activity of phenolphthalein and derivative compounds.
    Nieto A; García C; López de Haro MS
    Biochem Int; 1990; 21(2):305-11. PubMed ID: 2403370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid high-performance thin-layer chromatographic urine screen for laxative abuse.
    Perkins SL; Livesey JF
    Clin Biochem; 1993 Jun; 26(3):179-81. PubMed ID: 8330386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A soluble phenolphthalein laxative.
    ROSENTHAL M; CAIRNCROSS SE; GRAY MG
    Am J Dig Dis; 1947 Apr; 14(4):143-50. PubMed ID: 20294358
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative assessment of phenolphthalein and phenolphthalein glucuronide: is phenolphthalein glucuronide a better laxative?
    Anand BS; Torres E; Operkun A; Graham DY
    Aliment Pharmacol Ther; 1994 Oct; 8(5):559-62. PubMed ID: 7865650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems.
    Dunnick JK; Hailey JR
    Cancer Res; 1996 Nov; 56(21):4922-6. PubMed ID: 8895745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phenolphthalein as a laxative].
    KREBS KG
    Ther Ggw; 1952 Aug; 91(8):298-300. PubMed ID: 13005455
    [No Abstract]   [Full Text] [Related]  

  • 20. Laxative studies. I. Human threshold doses of white and yellow phenolphthalein.
    MUNCH JC; CALESNICK B
    Clin Pharmacol Ther; 1960; 1():311-5. PubMed ID: 14425224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.